Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Journal of Lipid Research|December 1, 1994
In vivo metabolism of apolipoprotein A-IV in severe hypertriglyceridemia: a combined radiotracer and stable isotope kinetic studyB Vergès, D Rader, J Schaefer, et al.
Neurology|March 1, 1991
Cerebrotendinous xanthomatosis: treatments with simvastatin, lovastatin, and chenodeoxycholic acid in 3 siblingsJ Peynet, A Laurent, P De Liege, et al.
Journal of Neurology|January 1, 1993
Plasma lipoproteins in cortical infarction versus transient ischaemic attacks: a case control studyM C Boutron, M Giroud, P Gras, et al.
Diabetes|January 1, 1997
Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDMB L Vergès, L Lagrost, G Vaillant, et al.
The Journal of Biological Chemistry|August 9, 1996
Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins. Physiological relevance in alcoholic patientsL Lagrost, A Athias, B Herbeth, et al.
Presse Medicale (Paris, France : 1983)|February 11, 1995
[Secondary hyperparathyroidism in the elderly. Apropos of 200 assays of intact parathormone]P Pfitzenmeyer, V Monnier, P d'Athis, et al.
The Journal of Biological Chemistry|June 2, 1995
Modulation of cholesterol efflux from Fu5AH hepatoma cells by the apolipoprotein content of high density lipoprotein particles. Particles containing various proportions of apolipoproteins A-I and A-IIL Lagrost, C Dengremont, A Athias, et al.
Diabetes & Metabolism|February 14, 2007
Effect of insulin treatment on plasma oxidized LDL/LDL-cholesterol ratio in type 2 diabetic patientsF Galland, L Duvillard, J M Petit, et al.
Diabetologia|June 7, 2008
Effects of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-ApoB kinetics in type 2 diabetesB Vergès, E Florentin, S Baillot-Rudoni, et al.
Journal of Lipid Research|October 1, 1996
Effect of lipid transfer activity and lipolysis on low density lipoprotein (LDL) oxidizability: evidence for lipolysis-generated non-esterified fatty acids as inhibitors of LDL oxidationL Viens, A Athias, G Lizard, et al.
Pageof 11